June 1, 2020 / 5:06 AM / a month ago

BRIEF-Abbvie And Jacobio Announce Strategic Collaboration To Advance Shp2 Inhibitors

June 1 (Reuters) - Abbvie Inc:

* ABBVIE AND JACOBIO ANNOUNCE STRATEGIC COLLABORATION TO ADVANCE SHP2 INHIBITORS

* UNDER TERMS OF AGREEMENT, ABBVIE WILL BE GRANTED AN EXCLUSIVE LICENSE TO SHP2 PORTFOLIO

* FINANCIAL TERMS WERE NOT DISCLOSED AND TRANSACTION IS SUBJECT TO CLEARANCE UNDER HART-SCOTT-RODINO ANTITRUST IMPROVEMENTS ACT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below